Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis. Metformin's mechanism is different from existing therapeutics which only treat symptoms, such as the blood pressure […]

Read more

Prexum

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PREXUM® perindopril (pronounced per-in-do-pril) Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PREXUM. It does not contain all the available information. It does not take the place of talking to your doctor, pharmacist or nurse. If you get any side […]

Read more

Sevelamer Apotex

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SEVELAMER APOTEX sevelamer carbonate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and […]

Read more

Perindo Combi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PERINDO® COMBI 4/1.25 perindopril (pronounced per-in-do-pril) and indapamide (pronounced in-dap-a-mide) Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PERINDO COMBI 4/1.25. It does not contain all the available information about this medicine. Reading this leaflet does not take the place […]

Read more

Denver dialysis centers separating patients with coronavirus to try to protect those at high risk – The Denver Post

Dialysis centers around the Denver area are setting aside certain hours or even entire facilities for patients who could have the new coronavirus, but it’s not guaranteed to protect their vulnerable patients. Patients with end-stage kidney disease are caught in a cruel bind as COVID-19 continues to spread: many have to risk death from infection multiple times a week to […]

Read more

One-fifth of US surgeons still overusing riskier procedure to create kidney dialysis access

Long-term hemodialysis is a lifesaver for approximately half a million patients in the United States with kidney failure (also known as end-stage renal disease, or ESRD) who are either waiting on or unsuitable for a kidney transplant. But before the external machinery can take over the function of the kidneys—filtering and cleansing wastes from the blood—a minor surgical procedure is […]

Read more

Insurance-related disparities in timely access to gold standard dialysis procedure

Patients with newly diagnosed kidney failure must wait for up to 3 months before they qualify for Medicare. A new study found that this short period of time without insurance is associated with delays in the placement and use of preferred methods for gaining access to the bloodstream for dialysis. The study, which appears in an upcoming issue of the […]

Read more